Donna L. Masterman, MD, is Assistant Clinical Professor of Neurology at the University of California, Los Angeles, UCLA School of Medicine. She is also Clinical and Research Core Director of the UCLA Alzheimer's Disease Research Center (ADR.C) and the UCLA Alzheimer's Disease Research Center of California (ARCC). In addition, Dr Masterman is Director of the Katherine and Benjamin Kagan Alzheimer's Disease Treatment Program, Director of the ADR.C and ARCC Continuity Care Clinic, and Attending Physician at the Movement Disorders Clinic, all at UCLA.

Dr Masterman earned her MD from the University of Washington School of Medicine in Seattle, during which time she completed a student internship focusing on Alzheimer's disease at the National Institute of Mental Health. She continued her postgraduate training at the University of Washington, completing an internship in internal medicine. She then performed a residency in clinical neurology and fellowships in behavioral neurology and movement disorders at UCLA.

Dr Masterman has written numerous journal articles, abstracts, and book chapters and has lectured nationally on dementia. She is also an ad hoc reviewer for several journals, including the Lancet and JAMA, and is on the editorial review board of Medicine and Behavior. She has also been an investigator on many dementia–related research projects. Dr. Masterman is a member of several professional organizations, including the American Academy of Neurology and the Movement Disorders Society, and is also a member of several advisory boards and committees. She was a founding member and is on the Board of Directors of the American Society of Experimental NeuroTherapeutics.

Dr Masterman has disclosed the following relationships:

• Grants/Research Support: Pfizer Inc

• Consultant: AstraZeneca, Aventis Pharmaceuticals Inc., Eisai Inc., Janssen Pharmaceutica, NeoTherapeutics, Pfizer Inc, Sanofi-Synthelabo Inc.

• Speakers' Bureau: Eisai Inc., Janssen Pharmaceutica, Novartis Pharmaceuticals Corporation, Pfizer Inc